Home > Financial Ratios > INDO US BIOTECH

INDO US BIOTECH
Working Capital/Sales

    Back to All Ratios
INDO US BIOTECH is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for INDO US BIOTECH
Please provide your vote to see the results

INDO US BIOTECH Last 5 Year Working Capital/Sales History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Working Capital/Sales(x) 1.481.311.301.441.99

What is the latest Working Capital/Sales ratio of INDO US BIOTECH ?

The latest Working Capital/Sales ratio of INDO US BIOTECH is 1.48 based on Mar2025 Standalone results.
Year Working Capital/Sales
Mar20251.48
Mar20241.31
Mar20231.30
Mar20221.44
Mar20211.99

How is Working Capital/Sales of INDO US BIOTECH Trending?

Years Working Capital/Sales % Change
Mar2025 1.48
12.98
Mar2024 1.31
0.77
Mar2023 1.3
-9.72
Mar2022 1.44
-27.64
Mar2021 1.99 -

Other Financial Ratios of INDO US BIOTECH


Compare Working Capital/Sales ratio of peers of INDO US BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDO US BIOTECH ₹202.1 Cr -26.4% -20.1% -48% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹10,893.1 Cr -0.4% -12.1% -9.1% Stock Analytics
KAVERI SEED COMPANY ₹4,150.9 Cr 12.7% -9.4% -24.4% Stock Analytics
VENKYS (INDIA) ₹1,830.9 Cr 3.2% -18.8% -22.5% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹881.6 Cr 0.2% -8.4% -35.8% Stock Analytics
MANGALAM GLOBAL ENTERPRISE ₹336.5 Cr 3.3% -17.1% -36.7% Stock Analytics


INDO US BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
INDO US BIOTECH

-26.4%

-20.1%

-48%

SENSEX

-2.5%

-6.1%

7%


You may also like the below Video Courses